These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 18694900)

  • 1. Thrombolytic therapy for acute stroke in the United Kingdom: experience from the safe implementation of thrombolysis in stroke (SITS) register.
    Lees KR; Ford GA; Muir KW; Ahmed N; Dyker AG; Atula S; Kalra L; Warburton EA; Baron JC; Jenkinson DF; Wahlgren NG; Walters MR;
    QJM; 2008 Nov; 101(11):863-9. PubMed ID: 18694900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR.
    Ahmed N; Wahlgren N; Grond M; Hennerici M; Lees KR; Mikulik R; Parsons M; Roine RO; Toni D; Ringleb P;
    Lancet Neurol; 2010 Sep; 9(9):866-74. PubMed ID: 20667790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
    Ahmed N; Kellert L; Lees KR; Mikulik R; Tatlisumak T; Toni D;
    JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR.
    Toni D; Ahmed N; Anzini A; Lorenzano S; Brozman M; Kaste M; Mikulik R; Putaala J; Wahlgren N;
    Neurology; 2012 Mar; 78(12):880-7. PubMed ID: 22402853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolytic therapy for acute stroke in Austria: data from the Safe Implementation of Thrombolysis in Stroke (SITS) register.
    Topakian R; Brainin M; Eckhardt R; Kiechl S; Ahmed N; Ferrari J; Iglseder B; Wahlgren NG; Lang W; Fazekas F; Willeit J; Aichner FT;
    Eur J Neurol; 2011 Feb; 18(2):306-311. PubMed ID: 20629718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolysis for acute ischaemic stroke with alteplase in an Asian population: results of the multicenter, multinational Safe Implementation of Thrombolysis in Stroke-Non-European Union World (SITS-NEW).
    Rha JH; Shrivastava VP; Wang Y; Lee KE; Ahmed N; Bluhmki E; Hermansson K; Wahlgren N;
    Int J Stroke; 2014 Oct; 9 Suppl A100():93-101. PubMed ID: 22988894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombolytic therapy for acute ischemic stroke. Experience of SITS (Safe Implementation of Thrombolysis in Stroke) register].
    Rodríguez-Yáñez M; Alvarez-Sabín J; Dávalos A; Díez-Tejedor E; Castillo J
    Neurologia; 2009 Jun; 24(5):288-91. PubMed ID: 19642029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SITS-MOST registry.
    Toni D; Lorenzano S; Puca E; Prencipe M
    Neurol Sci; 2006 Jun; 27 Suppl 3():S260-2. PubMed ID: 16752063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Belgian experience with intravenous thrombolysis for acute ischemic stroke.
    Vanacker P; Thijs V; Peeters A; Bruneel B; Laloux P; Druwé P; De Deyn P; Ahmed N; Wahlgren N; Vanhooren G;
    Acta Neurol Belg; 2010 Jun; 110(2):157-62. PubMed ID: 20873445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous recombinant tissue plasminogen activator for acute stroke in Poland: an analysis based on the Safe Implementation of Thrombolysis in Stroke (SITS) Registry.
    Kobayashi A; Czlonkowska A; Ahmed N; Romanowicz S; Glonek M; Nyka WM; Opala G; Wahlgren N;
    Acta Neurol Scand; 2010 Oct; 122(4):229-36. PubMed ID: 19919643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study.
    Wahlgren N; Ahmed N; Dávalos A; Hacke W; Millán M; Muir K; Roine RO; Toni D; Lees KR;
    Lancet; 2008 Oct; 372(9646):1303-9. PubMed ID: 18790527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous thrombolysis for acute ischaemic stroke: preliminary experience with recombinant tissue plasminogen activator in the UK.
    Walters MR; Muir KW; Harbison J; Lees KR; Ford GA
    Cerebrovasc Dis; 2005; 20(6):438-42. PubMed ID: 16230848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous thrombolysis in ischemic stroke patients with isolated homonymous hemianopia: analysis of Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR).
    Strbian D; Ahmed N; Wahlgren N; Kaste M; Tatlisumak T;
    Stroke; 2012 Oct; 43(10):2695-8. PubMed ID: 22811459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperdense middle cerebral artery sign on admission CT scan--prognostic significance for ischaemic stroke patients treated with intravenous thrombolysis in the safe implementation of thrombolysis in Stroke International Stroke Thrombolysis Register.
    Kharitonova T; Ahmed N; Thorén M; Wardlaw JM; von Kummer R; Glahn J; Wahlgren N
    Cerebrovasc Dis; 2009; 27(1):51-9. PubMed ID: 19018138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR).
    Ahmed N; Wahlgren N; Brainin M; Castillo J; Ford GA; Kaste M; Lees KR; Toni D;
    Stroke; 2009 Jul; 40(7):2442-9. PubMed ID: 19461022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study.
    Paciaroni M; Agnelli G; Caso V; Pieroni A; Bovi P; Cappellari M; Zini A; Nichelli P; Inzitari D; Nesi M; Nencini P; Pezzini A; Padovani A; Tassinari T; Orlandi G; Chiti A; Gialdini G; Alberti A; Venti M; Acciarresi M; D'Amore C; Luda E; Tassi R; Martini G; Ferrarese C; Beretta S; Trentini C; Silvestrelli G; Lanari A; Previdi P; Ciccone A; Delodovici ML; Bono G; Galletti G; Marcheselli S; Del Sette M; Traverso E; Riva M; Silvestrini M; Cerqua R; Consoli D; Monaco S; Toni D
    Cerebrovasc Dis; 2012; 34(5-6):430-5. PubMed ID: 23207482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.
    Wahlgren N; Ahmed N; Dávalos A; Ford GA; Grond M; Hacke W; Hennerici MG; Kaste M; Kuelkens S; Larrue V; Lees KR; Roine RO; Soinne L; Toni D; Vanhooren G;
    Lancet; 2007 Jan; 369(9558):275-82. PubMed ID: 17258667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
    Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
    Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolysis for acute stroke in Australia: outcomes from the Safe Implementation of Thrombolysis in Stroke registry (2002-2008).
    Simpson MA; Dewey HM; Churilov L; Ahmed N; Bladin CF; Schultz D; Markus R; Sturm JW; Levi CR; Blacker DJ; Jannes J; Lindley RI; Parsons MW
    Med J Aust; 2010 Oct; 193(8):439-43. PubMed ID: 20955119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA; Starr JA
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.